Skip to Main Content

Paper Details

Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
Oncotarget
11
2015
CHEK1, CHEK1/, CHEK1/2, CHEK1/2 mutant cell, CHEK2, CHEK2 checkpoint kinases, H2AX, RAD17, RAD17 knockdown cell lines, RAD17 wild-, Replication Factor C, Saccharomyces cerevisiae, WEE1, cancer, cancer cell lines, checkpoint, checkpoint kinase, checkpoint kinases, patients, tumor, tumor suppressor genes, tumors, yeast
Antineoplastic Agents, Biomarkers, Pharmacological, Cell Cycle, Cell Cycle Proteins, Checkpoint Kinase 1, Checkpoint Kinase 2, DNA Damage, DNA-Binding Proteins, Drug Discovery, HeLa Cells, Humans, Molecular Targeted Therapy, Mutation, Neoplasms, Nuclear Proteins, Protein Kinases, Protein-Tyrosine Kinases, RNA, Small Interfering, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Thiophenes, Urea
Author NameAffiliation
John Paul ShenUniversity of California San Diego
John Paul ShenMoores Cancer Center, University of California San Diego
Rohith SrivasUniversity of California San Diego
Rohith SrivasStanford University School of Medicine
Andrew M GrossUniversity of California San Diego
Jianfeng LiUniversity of Pittsburgh School of Medicine
Jianfeng LiUniversity of Pittsburgh Cancer Institute, Hillman Cancer Center
Jianfeng LiUniversity of South Alabama Mitchell Cancer Institute
Eric J JaehnigUniversity of California San Diego
Eric J JaehnigLudwig Institute for Cancer Research, University of California San Diego
Eric J JaehnigUniversity of California San Diego
Eric J JaehnigLudwig Institute for Cancer Research, University of California San Diego
Su Ming SunLeiden University Medical Center
Ana Bojorquez-GomezUniversity of California San Diego
Katherine LiconUniversity of California San Diego
Vignesh SivaganeshUniversity of California San Diego
Jia L XuUniversity of California San Diego
Kristin KlepperUniversity of California San Diego
Huwate YeernaUniversity of California San Diego
Daniel PekinUniversity of California San Diego
Chu Ping QiuUniversity of California San Diego
Haico van AttikumLeiden University Medical Center
Robert W SobolUniversity of Pittsburgh School of Medicine
Robert W SobolUniversity of Pittsburgh Cancer Institute, Hillman Cancer Center
Robert W SobolUniversity of South Alabama Mitchell Cancer Institute
Trey Ideker (CM4AI)University of California San Diego
Trey Ideker (CM4AI)Moores Cancer Center, University of California San Diego
Trey Ideker (CM4AI)University of California San Diego
Trey Ideker (CM4AI)University of California San Diego
Trey Ideker (CM4AI)Moores Cancer Center, University of California San Diego
Trey Ideker (CM4AI)University of California San Diego
  • 1 - 31

Datasets